[{"NetIncomeLoss_1_Q3_USD":-58571000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":146492.0,"CommitmentsAndContingencies_0_Q3_USD":null,"LiabilitiesNoncurrent_0_Q3_USD":6063000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":32400000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":155000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-376606000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":567043000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":43000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":265000.0,"AssetsCurrent_0_Q3_USD":723590000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":711643000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":16447000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":6704000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1516000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2018000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":358493000.0,"CommonStockSharesIssued_0_Q3_shares":146581624.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":645838000.0,"Assets_0_Q3_USD":782294000.0,"ShareBasedCompensation_3_Q3_USD":30655000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":10682000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":567043000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":135457.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":16.37,"GeneralAndAdministrativeExpense_1_Q3_USD":15916000.0,"OperatingLeaseLiability_0_Q3_USD":10907000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":149276000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":43050000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":11514000.0,"AssetsFairValueDisclosure_0_Q3_USD":645838000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":8255000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":1000000.0,"CommonStockValue_0_Q3_USD":6000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_3_Q3_USD":30655000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q3_USD":10706000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":819000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":573464000.0,"RestrictedCash_0_Q3_USD":5525000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":719700000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-191249000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-58733000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":7866000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":9168000.0,"OtherAssetsNoncurrent_0_Q3_USD":3385000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":68310000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":3711000.0,"Liabilities_0_Q3_USD":70453000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-65000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-162000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":44127000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":607000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":273000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-66000.0,"CommonStockSharesOutstanding_0_Q3_shares":146581624.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":155000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":283000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":30655000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":10706000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-142442000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":6642000.0,"LiabilitiesCurrent_0_Q3_USD":64390000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":54416000.0,"AccountsPayableCurrent_0_Q3_USD":24794000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":73835000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":9442000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":6704000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":2314000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.075,"ShortTermLeaseCost_3_Q3_USD":57000.0,"ShortTermLeaseCost_1_Q3_USD":26000.0,"AdditionalPaidInCapital_0_Q3_USD":1473472000.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":51213000.0,"OperatingLeasePayments_3_Q3_USD":5995000.0,"OperatingLeasePayments_1_Q3_USD":1893000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":39112000.0,"NetIncomeLoss_3_Q3_USD":-191184000.0,"LeaseCost_1_Q3_USD":3380000.0,"LeaseCost_3_Q3_USD":9751000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-761796000.0,"VariableLeaseCost_1_Q3_USD":1702000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_3_Q3_USD":-283000.0,"OperatingIncomeLoss_3_Q3_USD":-193403000.0,"OperatingIncomeLoss_1_Q3_USD":-58966000.0,"InvestmentIncomeInterest_3_Q3_USD":2219000.0,"InvestmentIncomeInterest_1_Q3_USD":395000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"OperatingLeaseCost_3_Q3_USD":5361000.0,"OperatingLeaseCost_1_Q3_USD":1652000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":782294000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":100000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2201000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":359000.0,"OperatingExpenses_3_Q3_USD":193403000.0,"OperatingExpenses_1_Q3_USD":58966000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":4667000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q3_USD":4667000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.41,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.4,"OtherLiabilitiesNoncurrent_0_Q3_USD":2352000.0,"StockholdersEquity_0_Q3_USD":711841000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":23456000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":646129000.0,"VariableLeaseCost_3_Q3_USD":4333000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":7196000.0,"ShortTermInvestments_0_Q3_USD":645838000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]